Biotech China 2014

Pharmacology: AstraZeneca

Total Score People Score Events Score
20 20 14
Date Event Presentation Speakers
September 7, 2014 EFMC-ISMC 2014 - XXIII International Symposium on Medicinal Chemistry The Discovery of AZD5069; a CXCR2 Antagonist In Phase II Clinical Trials for the Treatment of Asthma Rhona Cox
Identifying Selective Inhibitors of FGFR4 Kinase Kurt Pike
June 4, 2013 World Pharma Congress Cellular Impedance Measures of Cardiomyocyte Cultures for Screening Kinase Inhibitors Matthew Peters
FEATURED PRESENTATION: Predicting, Minimizing and Avoiding Human Adverse Drug Reactions Gerry Kenna
April 6, 2013 AACR Annual Meetings Drug Development Track: New Drugs on the Horizon 1 Co-Chairpersons: Lori S. Friedman, Genentech, Inc., South San Francisco, CA, and Simon Bailey, Pfizer, Inc., San Diego, CA Dennis Huszar
February 24, 2011 Targeting P13K / mTOR Signaling in Cancer Pharmacology of AZD8055, a selective mTOR kinase inhibitor Sylvie M. Guichard
February 13, 2011 Inositide Signaling in Pharmacology and Disease (X1) PI 3-Kinases (X2) | Using PI3K Pathway Inhibitors to Unravel the Pathway Sabina C. Cosulich
April 6, 2010 IBCs 5th Annual China 2010 Pharmaceutical R&D Summit 4 Case Study: Conducting Proof-of-Concept Studies in China Karen Atkin
June 10, 2009 Inaugural Risk Management and Drug Safety Strategies for Better Decision Making Steps to Identify Earlier and Better Assessment of Potential Risk of Compound in Development Lewis Kinter
June 9, 2009 Inaugural The Expanding Impact of New Animal Models in Drug Safety Biomarkers of Functional Toxicities: Identification and Assessment of their Translation into Humans Jean-Pierre Valentin
Zebrafish Assays as Early Safety Pharmacology Screens: Paradigm Shift or Red Herring? Jean-Pierre Valentin
June 3, 2009 7th Annual QT Prolongation and Safety Pharmacology Drug induced QT/QTc prolongation - Review of one-stage vs. two-stage methods to analyse clinical ECG data Jianguo Li
QT study design for oncology drugs Corina-Dana Dota,
Drug related change in the ECG - A novel biomarker for cardiac risk? Christer Gottfridsson
Increasing power through developing technologies - 12 lead ECG to continuous recording methods Corina-Dana Dota,
February 23, 2009 Advances and Progress in Drug Design VIII QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS Rupert Austin
February 10, 2009 10th Annual Phase I Clinical Trials New approaches for effectively managing complex Phase I trials Harsukh , Parmar
New directions for improving education and training for Phase I professionals Susanne Kihlblom
Achieving significant cost reduction through innovative Phase I outsourcing Susanne Kihlblom
October 21, 2008 Ion Channels as therapeutic targets Improving Ion Channel Lead Generation Capabilities by a Multi-Disciplinary Approach Michael Dabrowski
Progressing at an Accelerated Pace in Ion Channel Drug Discovery—Meeting the Top Two Challenges: Michael Dabrowski
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics Fingerprint Based Methods for Predicting Sites of Metabolism C Scott Boyer
Relevance of In Vitro and In Vivo Models to Cardiovascular Toxicity Tim Hammond
October 8, 2008 Accelerating Proof Of Concept Biomarkers in Early Stage Drug Development: Challenges and Opportunities - The Changing Face of Early Drug Development at AstraZeneca Victor Sandor
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.